April 19-20, 2024, Astana
SCIENTIFIC AND PRACTICAL CONFERENCE
LEFT BEFORE THE CONFERENCE START

HEALTH TECHNOLOGY ASSESSMENT (HTA) AS A TOOL TO DETERMINE PRIORITIES FOR HEALTHCARE DEVELOPMENT AND FUNDING

HTACONFERENCE.kz - is the foremost platform for exchanging knowledge and experience, conducting expert discussions, and forming recommendations on health technology assessment (HTA) in Eastern Europe and Central Asia (EECA).

We aim to enhance the efficiency of regional health systems by promoting the implementation of the best practices in decision-making and resource allocation.

With the support of Health Technology Assessment International (HTAi), HTA2024.kz is committed to using HTA to improve the quality and effectiveness of medical services in our regions.

Program Sign-in
WE ORGANIZE A CONFERENCE TO DEVELOP ECO-FRIENDLY
DECISION-MAKING PRACTICE IN HEALTHCARE
35
countries apply HTA*
2100
HTA specialists all over the world*
55
Agencies for HTA in the world*
* according to INAHTA

Past events

In 2022, we organized the first conference with the participation of internationally recognized HTA experts. The meeting, HTA2022.kz, was broadcasted live through YouTube and Zoom channels. Thanks to the engaging topics presented by speakers and our team's hard work, we attracted nearly 300 in-person and online listeners.

Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане Конференция в Астане
Program
** Organizing Committee reserves the right to change the conference program until the date of its holding

April 19

08:00am-09:00am
Conference Registration. Exhibition. Morning coffee
09:00am-10:50am
Welcome and Open Plenary Session
The Use of Health Technology Assessment in Decision Making for Funding and Universal Health Coverage
10:50am–11:10am
Coffee break. Networking
11:10am-1:00pm
Panel session 1
Improving Affordability, Availability, and Acceptability of Health Technologies
1:00pm-2:00pm
Lunch
2:00pm–3:30pm
Panel Session 2
The Value and Impact of HTA on the Health System
3:30pm–4:45pm
Panel session 3
Improving Healthcare and a Role for HTA
4:45pm–5:15pm
Coffee break. Networking
5:15pm–6:30pm
Discussion - Conclusions - Closing Remarks

April 20

09:00am–10:40am
Educational symposium 1
Access to Innovative Medicines: How to Optimize Access Processes in Kazakhstan? Grand Ballroom
09:00am–10:40am
Special Interest Group Discussion
Global Challenges for Pharmaceutical Pricing and Access to Medicines. Ishim & Ural Ballrooms
10:40am–11:10am
BREAKOUT SESSION
Approaches and Criteria for Assessing Biosimilars Eligibility for Reimbursement. Grand Ballroom
11:10am–11:30am
Coffee-break. Networking
11:00am–1:00pm
ROUNDTABLE
HTAi Policy Dialogue Eastern Europe & Сentral Asia. Ishim & Ural Ballrooms
by invitation only, coffee-break served
11:30am–1:10pm
Educational symposium 2
Opportunities for Expanding Access to High-Value Medicines as Part of Universal Health Coverage. Grand Ballroom
Sign-in
Download
Speakers
Rabia
Sucu
HTAi President, MSH Senior Principal Technical Advisor for Health Policy and Financing, Türkiye/US
Prof. Louis
Garrison
ISPOR Past President, Professor Emeritus, School of Pharmacy, University of Washington, Global Health Economics LLC, Seattle, WA, USA
Elena
Petelos
Chair for Real-World Evidence and Artificial Intelligence at HTAi; Vice President HTA at the European Public Health Association; Senior Lecturer in EBM and Senior Researcher in Public Health, University of Crete (Greece) and Maastricht University (The Netherlands)
Marco
Marchetti
Head of HTA Unit at National Agency for Regional Health Services, Co-Chair of Member State Coordination Group on HTA at European Commission, Italy
Eva
Turk
HTAi Board member; Senior Researcher, Center for Digital Health and Social Innovation, University of Applied Science St. Pölten, Austria and Ministry of Health, Slovenia
Alexander
Kostyuk
Advisor of the “KazSPOR” Kazakhstan Association of HTA, EBM and pharmacoeconomic research, Kazakhstan
Laura
Sampietro-Colom
HTAi Past President; Innovation Deputy Director, Head Evaluation of Innovation and New Technologies, Hospital Clínic Barcelona, Spain
Prof. Talgat
Nurgozhin
President of the “KazSPOR” Kazakhstan Association of HTA, EBM and pharmacoeconomic research, Kazakhstan
Ann
Single
HTAi Vice-President, HTAi Patient and Citizen Involvement Interest Group Outgoing Chair, Patient Voice Initiative Coordinator, Australia
Iñaki
Gutiérrez-Ibarluzea
HTAi Past President, Head of Knowledge Management and Evaluation in BIOEF, Spain
Iga
Lipska
Co-chair of HB-HTA Interest Group at HTAi, Chairwoman of the Board, Health Policy Institute, Poland
Birol
Tibet
Vice-Chair of the HTAi Early Career Network; Partner at the ECONiX Research; Vice-President, Turkish Evidence Based Medicine Association, Türkiye
Tanja
Novakovic
HTA and Health Economics expert, Director at ZEM Solutions Ltd, Serbia
Antonio
Migliore
Manager, Scientific Initiatives, HTAi, Canada
Esra
Meltem Koç
Director of Health Application and Research Center, Izmir Katip Celebi University, Izmir, Turkey
Güvenç
Koçkaya
Partner, ECONIX Research, MD&Health Economist, Lecturer at Yeditepe University, Türkiye
Zafar
Vakhidov
Partner at Vakhidov &Partners Law Firm, Kazakhstan/Uzbekistan
Alima
Almadiyeva
Scientific consultant, Kazakh Agency for Health Technology Assessment (KazAHTA), Kazakhstan
Organizers
Our supporters
Our sponsors
Location
SAAD Hotel Astana 2 Dostyq street
INDIVIDUAL REGISTRATION





Registration fees
Registration completed on April 18

Registration fees for 1 participant, tenge

EARLY

until April 12, 2024

NORMAL

after April 12, 2024

Universities / State healthcare organizations

/ Patients and their representatives

10 000

12 000

RDIs, RCs, republican healthcare organizations

15 00

18 000

Professional associations, for-profit organizations of private clinical practice, pharmacy business, science and education, healthcare consulting companies

60 000

70 000 

Industry (pharmaceutical companies, manufacturers of medical products) and their representative offices

135 000

160 000
Sign-in